World Pharma Today

Enhancing Drug Success with Female Cardiovascular Biomarkers

Yuvraj — Sat, 10 Oct 2026 08:46:12 +0000

Cardiovascular disease remains a leading cause of mortality among women, yet the mechanisms of disease progression often differ significantly from those observed in men. For many years, the pharmaceutical industry relied on generalized markers of heart health, which occasionally led to a lack of sensitivity in detecting early-stage issues in female patients. The emergence of […]

The post Enhancing Drug Success with Female Cardiovascular Biomarkers first appeared on World Pharma Today.

Optimizing Autoimmune Selection with Female Immune Biomarkers

Yuvraj — Sat, 10 Oct 2026 08:36:13 +0000

Autoimmune diseases affect women at a disproportionately high rate, with nearly 80 percent of all patients being female. Despite this staggering statistic, the underlying biological reasons for this disparity are only recently being understood with the necessary scientific depth. The pharmaceutical industry is now pivoting toward the identification of female immune biomarkers to improve how […]

The post Optimizing Autoimmune Selection with Female Immune Biomarkers first appeared on World Pharma Today.

Improving Therapeutic Development with Female Clinical Endpoints

Yuvraj — Sat, 10 Oct 2026 08:16:33 +0000

The pharmaceutical industry faces growing pressure to refine how therapeutic efficacy is measured across diverse patient populations. A significant shift in this progression involves the identification and integration of female clinical endpoints during the early and late stages of drug development. Historically, clinical research relied heavily on male-centric models, assuming that physiological responses would be […]

The post Improving Therapeutic Development with Female Clinical Endpoints first appeared on World Pharma Today.

What Goes Into Synthetic Urine? The Chemistry Behind Replicating a Biological Fluid

Yuvraj — Fri, 09 Oct 2026 13:02:05 +0000

Synthetic urine sounds simple until you look closely at what natural urine actually contains. At first glance, it may appear to be little more than water with a few dissolved substances, but urine is a chemically complex biological fluid whose composition reflects hydration, metabolism, diet, kidney function, and other physiological factors. Researchers who formulate artificial […]

The post What Goes Into Synthetic Urine? The Chemistry Behind Replicating a Biological Fluid first appeared on World Pharma Today.

Danaher Prepares to Introduce Advanced AI-Powered Laboratory

Yuvraj — Thu, 08 Oct 2026 13:36:21 +0000

In a significant step for pharmaceutical research, Danaher has announced plans to launch its first AI-powered autonomous research facility. Expected to become fully operational in early 2027 at the Abcam headquarters in Cambridge, UK, the upcoming AI autonomous lab will combine robotics, artificial intelligence, and proprietary technologies into a single, unified workflow. This closed-loop system […]

The post Danaher Prepares to Introduce Advanced AI-Powered Laboratory first appeared on World Pharma Today.

RABS upgrade for Inibsa, Achieving Annex 1 compliance together

Yuvraj — Thu, 08 Oct 2026 13:34:41 +0000

Compliance with EU GMP Annex 1 is one of the key challenges currently facing pharmaceutical manufacturers and CMOs. For Inibsa, a global leader in the dental market, this required upgrading its production facility with filling lines equipped with Restricted Access Barrier Systems. In collaboration with its long-standing partners Imco and Syntegon, Inibsa not only implemented […]

The post RABS upgrade for Inibsa, Achieving Annex 1 compliance together first appeared on World Pharma Today.

$1.8 Billion Commitment to Centralize Biological Data

Yuvraj — Thu, 08 Oct 2026 13:28:21 +0000

The United States government, alongside technology enterprises Meta Platforms and Alphabet, is officially joining forces with the nonprofit organization Biohub. This collaborative effort aims to construct comprehensive open datasets designed to train advanced AI models for biological research, elevating the total investment in this initiative to $1.8 billion. Financial Contributions and Strategic Partnerships In a […]

The post $1.8 Billion Commitment to Centralize Biological Data first appeared on World Pharma Today.

Milestone Leadership in Action: Behaviors That Build Winning Biotech Companies

Yuvraj — Thu, 08 Oct 2026 13:27:13 +0000

The biotech industry has never lacked brilliant scientists or bold ideas. What is often missing is leadership recognizing the behaviors required to build a great early-stage company are not the same as those required to take it to market — and willingness to adapt accordingly. In our recent report, From Science to Scale: Building Biotech […]

The post Milestone Leadership in Action: Behaviors That Build Winning Biotech Companies first appeared on World Pharma Today.

9 Best Application Lifecycle Management Solutions for MedTech

Yuvraj — Thu, 08 Oct 2026 07:40:40 +0000

Key Takeaways • Since the FDA’s QMSR took effect on February 2, 2026, design control evidence has to sit inside an ISO 13485-aligned quality system, not beside it. • Orcanos is the top pick, purpose-built for medical devices. It combines full engineering ALM (requirements, risk, test management, defect tracking, Jira, GitHub) with a native QMS […]

The post 9 Best Application Lifecycle Management Solutions for MedTech first appeared on World Pharma Today.

UCB Reports New EADV Data on Bimekizumab Treatment in HS

Yuvraj — Tue, 06 Oct 2026 13:04:07 +0000

UCB has announced new three-year data for bimekizumab in moderate to severe hidradenitis suppurativa (HS), with findings presented at the European Academy of Dermatology and Venereology (EADV) 2026 Congress in Vienna, Austria. The data indicate higher rates of complete resolution of inflammatory lesions among patients receiving bimekizumab treatment earlier, while biologic-naïve patients showed improved outcomes […]

The post UCB Reports New EADV Data on Bimekizumab Treatment in HS first appeared on World Pharma Today.